Delivery Order SPE2DB25D3018-SPE2DB25FUYPC
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,669.16 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Primaquine 26.3 mg tablets (100-count units). The contract utilizes firm fixed pricing under a non-set-aside competitive procurement and is scheduled for completion by September 16, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a leading pharmaceutical distributor and critical federal vendor...
- The Defense Logistics Agency awarded a $2,807.27 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Primaquine 26.3 mg tablets (100-count units). The contract utilizes firm fixed pricing with an ultimate completion date of July 21, 2025, and represents a non-set-aside, competitively awarded procurement. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Primaquine 26.3 mg tablets in a quantity of 100 units, valued at $1,816.32 with a firm fixed price structure. This award represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of July 16, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,461.74 to AmerisourceBergen Drug Corp for Primaquine 26.3 mg tablets (100-count) on June 16, 2025, with completion scheduled for June 17, 2025. This is a firm fixed-price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,633.04 firm fixed-price delivery order for Primaquine 26.3 mg tablets (100-count units) with an ultimate completion date of June 5, 2025. This non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Primaquine 26.3 mg tablets (100-count units) with a contract value of $1,713.32. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 29, 2025, for the supply of Primaquine 26.3 mg tablets in a quantity of 100 units, with a contract ceiling value of $1,231.50. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The contract is scheduled for ultimate completion by May 30, 2025, with...
- The Defense Logistics Agency awarded a delivery order valued at $1,788.91 to AmerisourceBergen Drug Corp for 100 tablets of Primaquine 26.3 mg. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by July 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Primaquine is an antimalarial medication used primarily for the treatment and prevention of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,635.24 to AmerisourceBergen Drug Corp for Primaquine 26.3 mg tablets (100 count) on August 25, 2025, with completion scheduled for August 26, 2025. This non-competitive delivery order represents a firm fixed-price pharmaceutical supply transaction utilizing the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order was fulfilled from the company's Conshohocken, Pennsylvania location,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Primaquine 26.3 mg tablets (100-count units) under a firm fixed-price contract. The contract has a ceiling value of $3,419.98 and an ultimate completion date of August 25, 2025. This award is unset-aside and was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB25D3018Indefinite Delivery Contract
- SPE2DB25D3018-SPE2DB25FUYPCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Primaquine 26.3 mg tablets (100-count units) valued at $1,373.34. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of September 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order. The delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract relationship with DLA Troop Support Medical. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supply support to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company holds a prime indefinite delivery vehicle with DLA Troop Support Medical (SPE2DX) valued at $999,999,999.00 through December 2026, which enables comprehensive global pharmaceutical support across multiple therapeutic domains. This specific delivery order for Primaquine, an antimalarial medication, exemplifies the company's role in supplying essential pharmaceutical products to support military healthcare operations. The firm's federal contract portfolio demonstrates consistent capability in fulfilling diverse medical procurement requirements through competitive processes and flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/18/25 |